STAAR Surgical Co
Closed
SectorHealthcare
22.55 -3.14
Overview
Share price change
24h
Min
22.15
Max
22.81
Income | 2.9M 8.1M |
|---|---|
Sales | 13K 94M |
P/E Sector Avg | 293.375 56.597 |
EPS | 0.18 |
Profit margin | 8.615 |
Employees | 921 |
EBITDA | 3M 13M |
Next Earnings | 3 Nov 2026 |
|---|
Market Cap | -74M 1.2B |
|---|---|
Previous open | 25.69 |
Previous close | 22.55 |
News Sentiment
By Acuity
30%
70%
63 / 339 Healthcare
STAAR Surgical Co Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
STAAR Surgical Co Forecast
Sentiment
By Acuity
63 / 339 Healthcare
News Sentiment
Bullish Evidence
Volatility
Below average
News Volume (RCV)
Below average
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About STAAR Surgical Co
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.